Skip to main content

Table 3 Incidences of LLL according to risk factors

From: Risk factors and a prediction model for lower limb lymphedema following lymphadenectomy in gynecologic cancer: a hospital-based retrospective cohort study

Variables Variable category No. of patients No. of patients with LLL (%) P-value
Age, (years) <56 127 40 (31.5) 0.089
≥56 137 57 (41.6)
BMI, (kg/m2) <25 194 66 (34.0) 0.145
≥25 70 31 (44.3)
Type of cancer Cervix 78 26 (33.3) 0.569
Body 113 46 (40.7)
Tube 2 1 (50.0)
Ovary 68 24 (35.3)
Vagina 3 0 (0)
Extent of Lymphadenectomy PLA 43 10 (23.3) 0.045
PLA + PALA 221 87 (39.4)
No. of LN <42 128 43 (33.6) 0.202
≥42 136 54 (39.7)
LN metastasis Yes 31 9 (29.0) 0.270
No 233 88 (37.8)
Retroperitoneal suture Yes 202 78 (38.6) 0.609
No 62 19 (30.6)
Radiation therapy Yes 17 9 (52.9) 0.298
No 247 88 (35.6)
Chemotherapy Yes 182 65 (35.7) 0.423
No 82 32 (39.0)
Herbal medicine Yes 10 6 (60.0) 0.108
No 254 91 (35.8)
Self-management education Yes 120 38 (31.7) 0.724
No 144 59 (41.0)
Infection Skin (cellulitis) 9 6 (66.7) 0.105
Lymphocyst 11 6 (54.5)
No 244 85 (34.8)
Lymphocyst formation Yes 93 46 (49.5) 0.003
No 171 51 (29.8)
  1. Definition of abbreviations: IQR Interquartile range, BMI Body mass index, No. Number, LLL Lower limb lymphedema, LN Lymph node, PLA Pelvic lymphadenectomy, PALA Para-aortic lymphadenectomy